RVMD

Q: What is the price of Revolution Medicines (RVMD) today?

The current price of Revolution Medicines (RVMD) is $182.08. The stock began the year trading around $79.65 and is currently priced at $182.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Revolution Medicines (RVMD) pay dividends?

Revolution Medicines (RVMD) did not pay dividends over the past year.

Revolution Medicines Inc.

Price

$182.08

return (12m)

393.31%

p/e

-23.53

p/bv

21.52

DIVIDEND YIELD

0.00%

RVMD price

Revolution Medicines

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RVMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

17.75%

3 months

96.82%

1 year

393.31%

2 years

372.57%

5 years

458.53%

10 years

0.00%

Fundamentals RVMD

review the fundamentals of Revolution Medicines shares

P/E

-23.53

Sector: -3.99 Industry: -3.99

P/S (PSR)

Sector: -4.23 Industry: -4.23

P/BV

21.52

Sector: 1.94 Industry: 1.94

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-60.86%

Sector: -66.51% Industry: -66.51%

ROE

-91.45%

Sector: -67.06% Industry: -67.06%

ROIC

-515.50%

Sector: -2,907.47% Industry: -2,907.47%

NET MARGIN

0.00%

Sector: -40.50% Industry: -40.50%

GROSS MARGIN

0.00%

Sector: 36.43% Industry: 36.43%

OPERATING MARGIN

0.00%

Sector: -39.36% Industry: -39.36%

EV/EBITDA

-24.16

Sector: -4.10 Industry: -4.10

EV/EBIT

-23.85

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

14.32

Sector: 1.43 Industry: 1.43

BVPS

7.58

Sector: 1.83 Industry: 1.83

EPS

-6.93

Sector: -2.16 Industry: -2.16

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.41 Industry: 0.41

LIABILITIES / ASSETS

0.33

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

48.95%

Sector: - Industry: -

Fundamentals RVMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
RVMD	-23.53	21.52	-91.45%	0.00%	$32.27 B	0.00%
JNJ	29.16	7.56	25.92%	2.06%	$613.48 B	21.83%
PFE	18.13	1.50	8.29%	7.21%	$135.79 B	11.83%
ABBV	123.36	-67.82	-54.98%	2.66%	$448.43 B	5.79%
NVO	11.11	6.71	60.40%	3.92%	$210.69 B	37.15%
MRK	31.50	6.13	19.45%	2.92%	$281.49 B	13.59%
AZN	28.09	6.16	21.93%	1.70%	$291.85 B	17.19%
GILD	17.12	6.73	39.33%	2.53%	$157.79 B	30.99%
BMY	15.13	5.47	36.19%	4.63%	$110.05 B	15.01%
ZTS	12.57	10.27	81.75%	2.62%	$33.22 B	27.79%
REGN	14.34	2.02	14.08%	0.60%	$63.43 B	29.65%
HALO	25.36	40.27	158.82%	0.00%	$8.85 B	23.13%
AMGN	24.81	21.06	84.87%	2.73%	$193.50 B	20.96%
MCK	19.23	-109.80	-570.98%	0.42%	$91.58 B	1.18%
VRTX	26.44	5.92	22.41%	0.00%	$114.71 B	35.51%
HRMY	14.13	2.26	16.00%	0.00%	$2.06 B	16.20%
CAH	33.52	-19.50	-58.20%	0.92%	$52.12 B	0.62%
BIIB	23.15	1.70	7.36%	0.00%	$31.76 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RVMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Revolution Medicines

Revolution Medicines Inc.

Average Investor10 user rating

4.0 (1 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

125

Employees

Revolution Medicines Inc. (United States) is listed on the Nasdaq and has a market capitalization of $32.27 billion, with shareholders equity totaling $1.50 Thousand.

The company employs approximately 125 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Revolution Medicines Inc. reported $- in revenue, generating net income of $-1.37 Thousand.

Key financial metrics include a P/E ratio of -23.53, a price-to-book (P/B) ratio of 21.52, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RVMD.

Market cap

$32.27 billion

Net worth

$1.50 Thousand

$1,499.92

Assets

$2.25 Thousand

$2,253.74

Total Shares Outstanding

198.00

000

Average Daily Trading Volume

$3.49 million

$3,492,570.00

Sector

Health Care

Industry

Biotechnology

RVMD

RVMD revenue and profits

Financial Results RVMD

DRAG THE FRAME TO SEE MORE DATA

RVMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$254.66 71,28% (12M)

P/E

29.16

2.06%

ROE

25.92%

P/BV

7.56

AZN - AstraZeneca

$188.41 37,18% (12M)

P/E

28.09

1.70%

ROE

21.93%

P/BV

6.16

ABBV - AbbVie

$253.35 44,63% (12M)

P/E

123.36

2.66%

ROE

-54.98%

P/BV

-67.82

PFE - Pfizer

$24.29 7,46% (12M)

P/E

18.13

7.21%

ROE

8.29%

P/BV

1.50

AMGN - Amgen

$358.33 33,17% (12M)

P/E

24.81

2.73%

ROE

84.87%

P/BV

21.06

GILD - Gilead Sciences

$127.88 17,74% (12M)

P/E

17.12

2.53%

ROE

39.33%

P/BV

6.73

ARGX - argenx

$887.18 58,39% (12M)

P/E

10.63

0.00%

ROE

20.81%

P/BV

2.21

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

JNJ - Johnson & Johnson

$254.66 71,28% (12 M)

P/L

29.16

2.06%

ROE

25.92%

P/VP

7.56

AZN - AstraZeneca

$188.41 37,18% (12 M)

P/L

28.09

1.70%

ROE

21.93%

P/VP

6.16

ABBV - AbbVie

$253.35 44,63% (12 M)

P/L

123.36

2.66%

ROE

-54.98%

P/VP

-67.82

PFE - Pfizer

$24.29 7,46% (12 M)

P/L

18.13

7.21%

ROE

8.29%

P/VP

1.50

AMGN - Amgen

$358.33 33,17% (12 M)

P/L

24.81

2.73%

ROE

84.87%

P/VP

21.06

GILD - Gilead Sciences

$127.88 17,74% (12 M)

P/L

17.12

2.53%

ROE

39.33%

P/VP

6.73

ARGX - argenx

$887.18 58,39% (12 M)

P/L

10.63

0.00%

ROE

20.81%

P/VP

2.21

Frequently Asked Questions

What is the price of Revolution Medicines (RVMD) today?

The current price of Revolution Medicines (RVMD) is $182.08. The stock began the year trading around $79.65 and is currently priced at $182.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Revolution Medicines (RVMD) pay dividends?

Revolution Medicines (RVMD) did not pay dividends over the past year.

Is Revolution Medicines (RVMD) a good investment?

Revolution Medicines (RVMD) is currently trading at $182.08 with a P/E ratio of -23.53. This represents a -1,351% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 393.31%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Revolution Medicines (RVMD) stock?

You can buy Revolution Medicines (RVMD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RVMD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Revolution Medicines (RVMD) yield today?

Over the past month, Revolution Medicines (RVMD) has returned 17.75% — 393.31% over the past year, and 458.53% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Revolution Medicines (RVMD) today at the current price of $182.08 your total investment would be $18,208.00.

Based on historical performance, the investment would have grown to approximately:

$89,821.88 after 1 year
$101,697.14 after 5 years
$18,208.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RVMD

Revolution Medicines Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RVMD

review the fundamentals of Revolution Medicines shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Revolution Medicines

Revolution Medicines Inc.

United States

12 years

2020

125

PROFIT X PRICE RVMD

Financial Results RVMD

RVMD cash flow

Asset, Revenue and Profit Growth - RVMD

RVMD balance sheet

BFRA - Biofrontera

JNJ - Johnson & Johnson

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

AMGN - Amgen

GILD - Gilead Sciences

ARGX - argenx

BFRA - Biofrontera

JNJ - Johnson & Johnson

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

AMGN - Amgen

GILD - Gilead Sciences

ARGX - argenx

Frequently Asked Questions